பிரிட்டிஷ் மருந்து நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UK pharma group Vectura agrees $1.4 billion takeover by Carlyle
SECTIONS
Last Updated: May 26, 2021, 12:27 PM IST
Share
Synopsis
Vectura s Chairman Bruno Angelici said the company had made strong progress since embarking on a strategy in 2019 to become a leading inhalation-focused CDMO, or contract development and manufacturing organisation.
Agencies
Vectura has 13 key inhaled and 11 non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development.
Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group.
Shareholders will receive 136 pence in cash plus a dividend of 19 pence for each share under the terms of the offer, representing a 32% premium on the ex-dividend closing price of the stock on Tuesday, Vectura said. Vectura s Chairma ....

United Kingdom , Paul Sandle , Kate Holton , Bruno Angelici , Vectura Group , Carlyle Group , Chairman Bruno Angelici , Clinical Development , British Pharmaceutical Company , ஒன்றுபட்டது கிஂக்டம் , பால் மணல் , கேட் ஹோல்டன் , கார்லைல் குழு , மருத்துவ வளர்ச்சி , பிரிட்டிஷ் மருந்து நிறுவனம் ,